350 related articles for article (PubMed ID: 32222124)
1. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
Dale HF; Lied GA
Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota Manipulation in Irritable Bowel Syndrome.
Mazzawi T
Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889051
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for managing irritable bowel syndrome.
El-Salhy M; Mazzawi T
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
5. Dysbiosis in Irritable Bowel Syndrome.
Abraham P; Pratap N
J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
[TBL] [Abstract][Full Text] [Related]
6. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
Pearson JS; Whorwell PJ
Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
[TBL] [Abstract][Full Text] [Related]
7. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
Herndon CC; Wang YP; Lu CL
Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
[TBL] [Abstract][Full Text] [Related]
8. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
12. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
13. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
19. The Intestinal Microbiota and Irritable Bowel Syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
[TBL] [Abstract][Full Text] [Related]
20. [Microbiota and irritable bowel syndrome: A critical inventory].
Enck P; Mazurak N
Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
